Approximately 10% of EGFR mutant NSCLC is classified as the uncommon subtypes (91), including G719X, L861Q, S768I, and exon 20 insertion, which have different clinicopathological characteristics and response to EGFR TKIs (92–96). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.